Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. BA

Go back to Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
(NASDAQ: SILO) Delayed: 2.58 -0.07 (2.64%)
Previous Close $2.65    52 Week High $ 
Open $2.64    52 Week Low $ 
Day High $2.73    P/E N/A 
Day Low $2.50    EPS $ 
Volume 45,449